Mekong Capital has completed the investment of $ 15 million in Gene Solutions (Gene Solutions) with a strategy of developing advanced gene tests, reasonable expenses for Vietnamese people.Gene Solutions is a pioneer company in the field Medical genetics in Vietnam. The company leads the market in the market of reproductive health care genes with abnormal screening tests in pregnancy and reproductive support. Besides, the company also provides tests Supporting understanding and exploring themselves through genetic analysis, cancer risk control and genetic diseases. The company also penetrates and develops the application of genetic testing technology in rare disease diagnostic support and cancer target treatment
. To date, Gene Solutions has implemented more than 250,000 different genetic tests, with a network work at 2,000 hospitals and clinics and 2,500 doctors and health workers stretching across the country. With the goal of building a solid foundation from the research team, besides the development of distribution networks and heads MEF IV will help Gene Solutions to speed up the expansion of advanced technology applications in genetic testing, and strengthen the position in the market, soon realize long-term vision: Serving, improving strength Healthy community with advanced gene solutions, quality with the most reasonable cost. Gene Solutions is the last sixth and latest company in the portfolio of Mekong Enterprise Fund IV published
Making, Gene Solutions CEO said, when founding Gene Solutions in 2017, genetic tests are expensive Very high fees and most Vietnamese people cannot reach. "We noticed Mekong Capital very" different ". They are interested in our vision and have also shown unprecedented commitments with us. We believe that the cooperation with Mekong Capital will accelerate the progress of realizing our vision, "Mr. Nghia said. While, Mr. Chris Freund, General Manager of Mekong Capital, said, 3 houses The co-founder of Gene Solutions has built a breakthrough vision for the future of the health sector in Vietnam. "Their goal is to provide accurate, convenient genetic tests with reasonable costs for goods Million Vietnamese people, contribute to early detection and improve the quality of life for many people in Vietnam. They will develop breakthrough new genetic tests, helping Vietnam become a place to research and develop important advanced biotechnology of the world, "said Chris Freund. So far, funds of Mekong Capital has completed 41 unlisted equity investment, including 27 completely divestments
Mekong Capital has managed 5 funds, two of which are operating. The companies have been and are in the Mekong Capital's portfolio are among the fastest growing companies and lead the market in consumer goods in Vietnam such as retail, restaurants, consumer goods, distribution and education Mobile, Golden Gate, Masan Consumer, Traphaco, Phu Nhuan Gem Gold, ICP, Viet-Australia International School, F88, Pharmacity, Yola, Pizza 4P's, King Mattress, ABA Cooltrans and Nhat Logistics etcMEF IV will Continuing Mekong Capital's strategy in investing in Vietnamese private enterprises, focusing on companies in the consumer sector. Good growth thanks to the increase in demand of domestic consumers and the application of modern business methods. Consumer case, fast consumer goods (FMCG) and health care.TV . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
